Enforcement Report - Week of April 13, 2022
Enforcement Report - Week of February 17, 2021
Hallettsville Pharmacy (Producer of Non Sterile Drugs) Receives FDA Form 483
Foothills Professional Pharmacy Receives FDA Form 483
Reed Pharmacy Receives FDA Form 483
Enforcement Report - Week of January 17, 2018
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (NRI.TO), formerly Nuvo Research Inc., a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that its board of directors has appointed Jesse Ledger to the position of President effective immediately.